# MRD Test in Common Risk Stage II Colorectal Cancer

> **NCT05795010** · — · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 60 (estimated)

## Conditions studied

- Stage II Colorectal Cancer

## Interventions

- **OTHER:** MRD test

## Key facts

- **NCT ID:** NCT05795010
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-30
- **Primary completion:** 2023-04-10
- **Final completion:** 2023-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05795010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05795010, "MRD Test in Common Risk Stage II Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05795010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*